Methadone linked to 30 percent of painkiller overdoses

The prescription drug methadone is linked to over 30 percent of painkiller overdose deaths, according to a report released by the Centers for Disease Control (CDC) and Prevention Tuesday.

"Death from opioid overdose have increased four-fold in the past decade, and now accounts for nearly a third of opioid-associated deaths," said CDC Director Thomas Frieden.

Still, the drug accounted for some two percent of total painkiller prescriptions in the US in 2009.

Researchers assessed national data from 1999 to 2010 as well as data for 2009 from 13 states covered by a drug-related death surveillance network. Six times as many people died of methadone overdose in 2009 than in 1999.

Methadone has been used as a successful treatment for for several decades. In recent years, more doctors have prescribed the drug as a painkiller.

Risks associated with methadone are greater than other painkillers, because the drug often builds up in the patient's system and may disrupt breathing and heart rhythm.

Methadone used as a heroin substitution treatment did not appear to be a part of rise in , the CDC reported.

add to favorites email to friend print save as pdf

Related Stories

Deaths from painkiller overdose triple in decade

Nov 01, 2011

The number of overdose deaths from powerful painkillers more than tripled over a decade, the government reported Tuesday - a trend that a U.S. health official called an epidemic, but one that can be stopped.

Recommended for you

Determine patient preferences by means of conjoint analysis

3 hours ago

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

User comments